Trial intelligence / Profile preview

Metformin for Glucocorticoid Side Effects in Autoimmune Uveitis

NCT03525028Unknown

Sponsor
Tianjin Medical University
Start
Nov 2018
Primary completion
Jan 2023
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in autoimmune uveitis comparing Metformin group with Placebo group (2 arms). Primary endpoint: The incidence of abnormal metabolic indexes at 24 weeks. Status: unknown.

02

Drugs

metformin
03

Conditions

autoimmune uveitis

Beyond the preview

Go deeper on NCT03525028.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03525028.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call